Butterfly gliomas: to biopsy or to ablate – a longitudinal cohort study - Top-Institutions - MDSpire

Butterfly gliomas: to biopsy or to ablate – a longitudinal cohort study

  • By

  • Vratko Himic

  • Morgan Leigh Johnson

  • Anshul Ratnaparkhi

  • Roxanne C. Mayrand

  • Jay Chandar

  • Vaidya Govindarajan

  • Daniel C. Kreatsoulas

  • Arman Jahangiri

  • Zachary C. Gersey

  • Daniel M. Aaronson

  • Ricardo J. Komotar

  • Micheal E. Ivan

  • Ashish H. Shah

  • June 5, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    University of Miami
    University of Miami

    Miami, FL

    Key Differentiators

    • Neurosurgery

  • #2

    our hospital
    our hospital

    Unknown, Unknown

    Key Differentiators

    • Neurosurgery

  • #3

    Medical Center-University of Freiburg
    Medical Center-University of Freiburg

    Freiburg, BW

    Key Differentiators

    • Neurosurgery

Original Source(s)

Butterfly gliomas: to biopsy or to ablate – a longitudinal cohort study

  • by Vratko Himic, Morgan Leigh Johnson, Anshul Ratnaparkhi, Roxanne C. Mayrand, Jay Chandar, Vaidya Govindarajan, Daniel C. Kreatsoulas, Arman Jahangiri, Zachary C. Gersey, Daniel M. Aaronson, Ricardo J. Komotar, Micheal E. Ivan, Ashish H. Shah

  • June 5, 2026

Related Content

Radiomics and deep learning in upper tract urothelial carcinoma: advancing preoperative risk stratification and clinical decision-making

Feasibility and strategy analysis of radiotherapy consolidation following immunotherapy for stage IV esophageal squamous cell carcinoma

2026 AACR Prostate Cancer Highlights

The Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute presents a succinct summary of all the prostate cancer clinical updates you need to know from AACR 2026.

  • June 17, 2026

  • 1 min